Memorandum of understanding between the NHS and pharmaceutical companies Patent information and availability of generic medicinesNovember 13th, 2020
FiledNovember 13th, 2020The NHS National Patent Group (NPG) was established to monitor patent expiries, gather intelligence on potential generic/ biosimilar launches and plan for their introduction into the NHS in a timely and safe manner. The group is comprised of senior members of the Specialist Pharmacy Service (Medicines Information and Procurement) and NHS England Commercial Medicines Unit and Specialised Commissioning.